A Study of the Intervention of Time-restricted Eating in High-risk Populations of GDM

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-50
SponsorFudan University

About this trial

This is a randomized controlled trial, aiming to investigate whether a time-restricted eating (TRE) can reduce the incidence of gestational diabetes mellitus (GDM) in high-risk pregnant women. Investigators intend to conduct a 3-month randomized controlled study to compare the effects of 10-hour TRE and habitual eating time on GDM .

Eligibility criteria

Qualifiers

Aged 18-50 years;

The risk for GDM includes overweight or obesity (BMI ≥ 24 kg/m2 before pregnancy), first-degree relative with diabetes, history of cardiovascular disease, hypertension (≥130/80 mmHg or on therapy for hypertension), HDL cholesterol level < 1 mmol/L and/or a triglyceride level > 2.8 mmol/L, history of GDM, history of macrosomia delivery, individuals with polycystic ovary syndrome, repeated positive fasting urine glucose in the first trimester, or age>45 years according to Guideline of Diagnosis and Treatment of Hyperglycemia in Pregnancy (2022);

Less than 14 weeks of gestation;

Able to read and complete questionnaires in Chinese;

Disqualifiers

Pregestational diabetes (including diabetes diagnosed before conception; fasting blood glucose ≥ 7.0 mmol/L or HbA1c ≥ 6.5% in the first trimester; typical symptoms of hyperglycemia or hyperglycemic crisis with optional blood glucose ≥ 11.1 mmol/L);

Impaired glucose tolerance (including fasting blood glucose ≥ 5.6 mmol/L or two fasting blood glucose ≥ 5.1 mmol/L in the first trimester);

Current or recent use of drugs that affect glucose metabolism such as metformin, glucocorticoids and Orlistat;

Severe comorbidities (including cardiac diseases, kidney diseases, hepatopathy, autoimmune diseases, uncontrolled thyroid disease, previous or current malignant tumors, etc.);

Trial design

Treatments tested in this trial

  • Time-limited eating

Treatment groups

240 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Fudan University

Lead sponsor

Obstetrics & Gynecology Hospital of Fudan University

Sponsor institution

Shenzhen Maternity & Child Healthcare Hospital

Collaborator